Article

(2021) Anti-VEGF agents: As appealing targets in the setting of COVID-19 treatment in critically ill patients. International Immunopharmacology. p. 8. ISSN 1567-5769

(2021) Arglabin could target inflammasome-induced ARDS and cytokine storm associated with COVID-19. Molecular Biology Reports. pp. 8221-8225. ISSN 0301-4851

(2021) Emerging Novel Approaches for the Enhanced Delivery of Natural Products for the Management of Neurodegenerative Diseases. Journal of Molecular Neuroscience. p. 24. ISSN 0895-8696

(2021) Harnessing polyphenol power by targeting eNOS for vascular diseases. Critical Reviews in Food Science and Nutrition. p. 26. ISSN 1040-8398

(2021) The neuroprotective effects of polyphenols, their role in innate immunity and the interplay with the microbiota. Neuroscience and Biobehavioral Reviews. pp. 437-453. ISSN 0149-7634